Multicentre randomized phase II study with Gemcitabine (GEM) plus cisplatin (CDDP) in patients with stage IIIB-IV NSCLC

被引：0
|
作者：
Ricci, S
Antonuzzo, A
Galli, L
Algeri, R
Bonifazi, V
Andrei, A
Petruzzelli, S
Dupre, C
Pegna, AL
Conte, PF
机构：
[1] Osped S Chiara, Pisa, Italy
[2] Osped Civile Misericordia, Grosseto, Italy
[3] Osped Cisanello, Pisa, Italy
[4] Osped Careggi, Florence, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
456
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [1] A feasibility study of vinorelbine (VNR) and gemcitabine (GEM) in inoperable stage IIIb-IV NSCLC
    Mattson, K
    Tamminen, K
    Nikkanen, V
    Viren, M
    Isokangas, OP
    LeBras, F
    Barbet, I
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1066 - 1066
  • [2] A feasibility study of vinorelbine (VNR) and gemcitabine (GEM) in inoperable stage IIIb-IV NSCLC.
    Mattson, K
    Tamminen, K
    Nikkanen, V
    Viren, M
    Isokangas, OP
    Delgado, FM
    Barbet, I
    BRITISH JOURNAL OF CANCER, 1998, 78 : 31 - 31
  • [3] A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC)
    Ginopoulos, P
    Mastronikolis, NS
    Giannios, J
    Karana, A
    Siabi, V
    Karvelas, F
    Rathossis, S
    Apostolopoulos, N
    Mastorakou, A
    LUNG CANCER, 1999, 23 (01) : 31 - 37
  • [4] Treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) with Gemcitabine, ifosfamide, cisplatin (GIP): A phase II study
    Boni, C
    Bisagni, G
    Savoldi, L
    Moretti, G
    Vignoli, R
    Franciosi, V
    Pezzola, A
    De Pas, M
    Zadro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 91
  • [5] Efficacy of the combination cisplatin-vinorelbin followed by docetaxel in untreated unresectable patients with NSCLC (stage IIIB-IV). A phase II study
    Piantedosi, F. V.
    Bianco, A.
    Caputo, F.
    Pisanti, C.
    Pontillo, A.
    Curcio, C.
    Crispino, C.
    Giuliarini, G.
    Hengeller, M.
    Marsico, S. A.
    Chianca, P.
    ANNALS OF ONCOLOGY, 2005, 16 : 23 - 23
  • [6] A Phase II Study of Gemcitabine-Cisplatin plus Necitumumab for Stage IV Sq-NSCLC
    Corral, Jesus
    Ponce, Santiago
    Aerts, Joachim G.
    Tsai, Chun-Ming
    Hao, Desiree
    Cadranel, Jacques
    Beck, J. Thaddeus
    Kim, Sang-We
    Varea, Rocio
    Chao, Grace
    Barriga, Susana
    Paz-Ares, Luis
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S424 - S424
  • [7] Gemcitabine plus carboplatin (GCB) versus cisplatin plus vinblastin (CV) in stage IIIB-IV non-small cell lung cancer (NSCLC).
    Grigorescu, AC
    Draghici, NI
    Gutulescu, N
    ANNALS OF ONCOLOGY, 2000, 11 : 110 - 110
  • [8] Gemcitabine(GEM)-cisplatin (CDDP): A schedule finding phase I/II study
    Kroep, JR
    Peters, GJ
    Van Moorsel, CJA
    Vermorken, JB
    Postmus, PE
    Catik, A
    Pinedo, HM
    Van Groeningen, CJ
    ANNALS OF ONCOLOGY, 1998, 9 : 126 - 126
  • [9] Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC):: a multicentre phase II clinical trial
    Palmeri, S
    Leonardi, V
    Gebbia, V
    De Bella, MT
    Ferraù, F
    Faillù, G
    Spatafora, M
    Valenza, R
    Di Vita, G
    Vitello, S
    Carroccio, R
    Sciortino, G
    Vaglica, M
    Accurso, V
    Agostara, B
    Licata, G
    LUNG CANCER, 2001, 34 (01) : 115 - 123
  • [10] Epirubicine/gemcitabine combination in stage IIIb-IV non small cell lung cancer (NSCLC). Preliminary data of a phase I/II study
    Illiano, A.
    Battiloro, C.
    Rocco, D.
    Formato, R.
    Iaffaioli, R., V
    ANNALS OF ONCOLOGY, 2006, 17 : XI23 - XI23
12345